Provider of ambulatory-focused technology solutions, NextGen Healthcare Inc. posted Q3 FY22 sales of $149.7 million.

Given current market volatility, buying the dip in fundamentally sound stocks could be a smart move. Thus, the recent dips in Corcept Therapeutics, NextGen Healthcare, and Core Molding Technologies could represent the perfect buying opportunity.

Small-cap stocks have been making a solid comeback in this scenario thanks in part to government stimulus checks, especially to  small- and medium-sized businesses (SMBs), and their access to cheap capital amid the low interest rate environment.